Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 1, 2020, Pages

  Allida, Sabine ^a   Cox, Katherine Laura ^a   Hsieh, Cheng Fang ^b   Lang, Helen ^c   House, Allan ^d   Hackett, Maree L ^a,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Division of Psychological and Social Medicine ^*  (Canada)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANIRACETAM; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DEANXIT; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LITHIUM SALT; METHYLPHENIDATE; MOCLOBEMIDE; NEFIRACETAM; NORTRIPTYLINE; PAROXETINE; PLACEBO; REBOXETINE; SERTRALINE; TRAZODONE; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; ESCITALOPRAM; INDELOXAZINE; MAPROTILINE; MIANSERIN; MOOD STABILIZER; PIRACETAM;

BARTHEL INDEX; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CEREBROVASCULAR ACCIDENT; COGNITIVE BEHAVIORAL THERAPY; COMPARATIVE EFFECTIVENESS; DEPRESSION; FUNCTIONAL INDEPENDENCE MEASURE; GENERAL HEALTH QUESTIONNAIRE; GERIATRIC DEPRESSION SCALE; GROUP THERAPY; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOTIVATIONAL INTERVIEWING; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATIENT COUNSELING; PHYSICAL PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; PROBLEM SOLVING THERAPY; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; REVIEW; SYSTEMATIC REVIEW; ADVERSE OUTCOME; AGING; ANXIETY; ATTENTION; COGNITION; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; DISTRESS SYNDROME; FOLLOW UP; FRENCHAY ACTIVITIES INDEX; HEMISPHERIC STROKE SCALE; INCIDENCE; MENTAL HEALTH; MENTAL HEALTH CARE; MORTALITY; NOTTINGHAM HEALTH PROFILE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SAFETY; RISK FACTOR; SCORING SYSTEM; SOCIAL BEHAVIOR; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; ELECTROTHERAPY; META ANALYSIS; PROCEDURES; PSYCHOLOGY;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; ELECTRIC STIMULATION THERAPY; HUMANS; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 85078350013     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003437.pub4     Document Type: Review

References (253)

1. Alexopoulos GS, Wilkins VM, Marino P, Kanellopoulos D, Reding M, Sirey JA, et al. Ecosystem focused therapy in poststroke depression: a preliminary study. International Journal of Geriatric Psychiatry 2012;27:1053-60. x-wiley/crsRef/12667647
2. Kiosses DN, Alexopoulos GS, Wilkins V. Ecosystem focused therapy for treating older depressed stroke survivors. http://www.strokecenter.org/trials/clinicalstudies/ecosystem-focused-therapy-for-treating-older-depressed-stroke-survivors (first received 22 July 2009). x-wiley/crsRef/12667648
3. NCT00944762. Ecosystem focused therapy for treating older depressed stroke survivors. http://ClinicalTrials.gov/show/NCT00944762 (first received 23 July 2009). x-wiley/crsRef/12667649
4. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor, citalopram. Journal of Neurology 1994;241 Suppl 1:S42. x-wiley/crsRef/12667651
5. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25(6):1099-104. x-wiley/crsRef/12667652
6. Andersen G, Vestergaard K, Lauritzen L. Post-stroke depression treated with citalopram. Acta Neurologica Scandinavica 1994;89 Suppl 155:20. x-wiley/crsRef/12667655
7. Andersen G, Vestergaard K, Lauritzen L. Post-stroke depression treated with citalopram - a selective serotonin reuptake inhibitor. Canadian Journal of Neurological Sciences 1993;20(Suppl 4):S115. x-wiley/crsRef/12667653
8. Andersen G, Vestergaard K, Lauritzen L. Post-stroke depression treated with citalopram a selective serotonin reuptake inhibitor. Proceedings of the 7th Scandinavian Meeting on Cerebrovascular Disease. Jyvaskyla, Finland, 14-17 August 1993:54. x-wiley/crsRef/12667654
9. Andersen G, Vestergaard K, Lauritzen LU. Effective treatment of depression following apoplexy with citalopram. Ugeskrift for Laeger 1995;157(14):2000-3. x-wiley/crsRef/12667656
10. Flicker C, Andersen G, Bayer L. A placebo-controlled study of citalopram treatment for post-stroke depression. Proceedings of the 11th Annual Meeting of the American Association for Geriatric Psychiatry. San Diego, California, USA, 1998. x-wiley/crsRef/12667657
11. Cao WW, Yu JM, Sun SY, Sun YB, Luan L, Cai XJ, et al. Group psychotherapy in treatment of post stroke depression [???????????????????]. Chinese Mental Health Journal 2009;23(2):100-4. x-wiley/crsRef/12667659
12. Cao WW, Yu JM, Sun SY, Sun YB, Luan L, Cai XJ, et al. Group psychotherapy in treatment of post stroke depression [???????????????????]. Chinese Mental Health Journal 2009;23(2):100-4. x-wiley/crsRef/12667661
13. Chen Y-P, Mei Y-W, Sun S-G, Bao M, Yu S-C. Evaluation of frequency repetitive transcranial magnetic stimulation for post-stroke depression and neurologic impairment. Zhongguo Linchuang Kangfu 2005;9:18-9. x-wiley/crsRef/12667663
14. Cullen B, Pownall J, Cummings J, Baylan S, Broomfield N, Haig C, et al. Positive PsychoTherapy in ABI Rehab (PoPsTAR): a pilot randomised controlled trial. Neuropsychological Rehabilitation 2018;28(1):17-33. x-wiley/crsRef/12667665
15. Du DQ, Wu YB. Living ability and cognitive function ameliorated by low frequency repetitive transcranial magnetic stimulation in patients with post-stroke depression: comparison with drug plus psychological treatment. Zhongguo Linchuang Kangfu 2005;9(16):22-3. x-wiley/crsRef/12667667
16. Fan X. Duloxetine combined with repetitive transcranial magnetic stimulation in the treatment of post stroke depression effect. Chinese Journal of Practical Nervous Disease 2014;1:102-3. x-wiley/crsRef/12667669
17. Fang Y, Mpofu E, Athanasou J. Reducing depressive or anxiety symptoms in post-stroke patients: pilot trial of a constructive integrative psychosocial intervention. International Journal of Health Sciences 2017;11(4):53-8. x-wiley/crsRef/12667671
18. Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression: a three months double-blind placebo-controlled study with an open-label long-term follow up. Journal of Neurology 2003;250(3):347-51. x-wiley/crsRef/12667673
19. Gao J, Lin M, Zhao J, Bi S, Ni Z, Shang X. Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke. Clinical Rehabilitation 2017;31(1):71-81. x-wiley/crsRef/12667675
20. Gao J, Lin M, Zhao J, Bi S, Ni Z, Shang X. Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke. Clinical Rehabilitation 2017;31(1):71-81. x-wiley/crsRef/12667677
21. Gu SY, Chang MC. The effects of 10-Hz repetitive transcranial magnetic stimulation on depression in chronic stroke patients. Brain Stimulation 2016;10:270-4. x-wiley/crsRef/12667679
22. ACTRN12609000741280. Evaluation of brief interventions for enhancing early emotional adjustment following stroke: a pilot randomised controlled trial. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=308355&isClinicalTrial=False (first received 25 August 2009). x-wiley/crsRef/12667681
23. Hoffmann T, Ownsworth T, Eames S, Shum D. Evaluation of brief interventions for enhancing early emotional adjustment following stroke: a pilot randomised controlled trial. Topics in Stroke Rehabilitation 2015;22(2):117-26. x-wiley/crsRef/12667682
24. Ownsworth T, Hoffman T, Stemm B, Evans E, Howlett J, Shum D. Early cognitive appraisals, benefit finding and emotional status after stroke: pre-intervention associations and preliminary intervention findings. Brain Impairment 2011;12:66. x-wiley/crsRef/12667683
25. Huang, XH. The clinical correlation study and the effect of fluoxetine intervention on poststroke depression. Chinese Journal of Clinical Rehabilitation 2002;6(15):2296-7. x-wiley/crsRef/12667685
26. Jiang B, Lu W, Song X-W, Tan L-M, Hu Z-P. The effect of poststroke depression interventions on the recovery of neurological function. Modern Rehabilitation 2001;5(3):29-30. x-wiley/crsRef/12667687
27. Jiang B, Lu W, Song X-W, Tan L-M, Hu Z-P. The effect of poststroke depression interventions on the recovery of neurological function. Modern Rehabilitation 2001;5(3):29-30. x-wiley/crsRef/12667689
28. Jiang X. Effect of transcranial magnetic stimulation combined with sertraline on neurological deficits in patients with acute cerebral infarction. Chinese Journal of Practical Nervous Disease 17;21:81-3. x-wiley/crsRef/12667691
29. Jiang X. Effect of transcranial magnetic stimulation combined with sertraline on neurological deficits in patients with acute cerebral infarction. Chinese Journal of Practical Nervous Disease 2014;17(21):81-3. x-wiley/crsRef/12667693
30. Jin H. Effect of repetitive transcranial magnetic stimulation on post stroke depression. Chinese Journal of Rehabilitation Medicine 2013;28(1):58-60. x-wiley/crsRef/12667695
31. Kerr D, Mackey E, Wijeratne T, McCann T. Nursing early motivational interviewing on poststroke depressive symptoms: pilot randomized controlled trial of the good mood intervention program. International Journal of Stroke 2014;19:245. x-wiley/crsRef/12667697
32. Kerr D, McCann T, Mackey E, Wijeratne T. Effects of early motivational interviewing on post-stroke depressive symptoms: pilot randomised study of the Good Mood Intervention program. International Journal of Nursing Practice 2018;24:1-8. x-wiley/crsRef/12667698
33. Kirkness CJ, Cain KC, Becker KJ, Tirschwell DL, Buzaitis AM, Weisman PL, et al. Randomized trial of telephone versus in-person delivery of a brief psychosocial intervention in post-stroke depression. BMC Research Notes 2017;10:500. x-wiley/crsRef/12667700
34. Kirkness CJ, Cain KC, Becker KJ, Tirschwell DL, Buzaitis AM, Weisman PL, et al. Randomized trial of telephone versus in-person delivery of a brief psychosocial intervention in post-stroke depression. BMC Research Notes 2017;10:500. x-wiley/crsRef/12667702
35. Kong Y, Dong WL, Liu CF. Fluoxetine for poststroke depression: a randomized placebo controlled clinical trial. Neural Regeneration Research 2007;2:162-5. x-wiley/crsRef/12667704
36. Lai J, Zeng G. The effect of using paroxetine to treat post stroke depression. Journal of Guangdong Medical College 2006;24(6):585-6. x-wiley/crsRef/12667706
37. Li L, Wang S, Ge H, Chen J, Yue S, Yu M. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression. Journal of Alternative & Complementary Medicine 2008;14(7):841-6. x-wiley/crsRef/12667708
38. Li N, Han Y. A study of efficacy mirtazapine merge rTMS to treatment of post-stroke depression. Chinese Journal of Trauma and Disability Medicine 2013;21(6):48-50. x-wiley/crsRef/12667710
39. Li L. Fluoxetine capsules combined with repetitive transcranial magnetic stimulation on depression after stroke treatment. Chinese Journal of Practical Nervous Disease 2014;17(20):105-6. x-wiley/crsRef/12667712
40. Flannaghan T. Cognitive behavioural psychotherapy for the treatment of depression after stroke. Unpublished. University of Nottingham, Nottingham, 2000. x-wiley/crsRef/12667714
41. Lincoln N. Pilot evaluation of cognitive behavioural treatment of depression after stroke. National Research Register 1996. x-wiley/crsRef/12667715
42. Lincoln NB, Flannaghan T. Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003;34:111-5. x-wiley/crsRef/12667716
43. Thomas SA, Lincoln NB. Factors relating to depression after stroke. British Journal of Clinical Psychology 2006;45:49-61. x-wiley/crsRef/12667717
44. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial. Stroke 2000;31:1482-6. x-wiley/crsRef/12667719
45. Kimura M, Tateno A, Robinson RG. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. American Journal of Geriatric Psychiatry 2003;11(3):320-7. x-wiley/crsRef/12667720
46. Lipsey JR, Robinson RG. Nortriptyline for post-stroke depression. Lancet 1984;1(8380):803. x-wiley/crsRef/12667722
47. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984;1(8372):297-300. x-wiley/crsRef/12667721
48. Liu X. The effect of repetitive transcranial magnetic stimulation on the treatment of post-stroke depression. Chinese Journal of Gerontology 2015;1:5621-2. x-wiley/crsRef/12667724
49. Lu Q, Zhang H-P, Yang S-P, Zhu Z-F. Study of low frequency repetitive transcranial magnetic stimulation in the treatment of post-stroke depression. Hainan Medical Journal 2016;27(12):1963-4. x-wiley/crsRef/12667726
50. Meng Y. Clinical study of transcranial magnetic therapy in the treatment of depression after cerebral infarction. Chinese Journal of Trauma and Disability Medicine 2015;23(5):141-2. x-wiley/crsRef/12667728
51. Barer D. A brief psychosocial-behavioral intervention reduced depression after stroke more than usual care: commentary. Annals of Internal Medicine 2010; Vol. 152:JC3-10. x-wiley/crsRef/12667730
52. Becker KJ, Buzaitis A, Cain KC, Fruin M, Kohen R, Teri L, et al. Brief psychosocial/behavioral intervention with antidepressant reduces post-stroke depression significantly more than antidepressant alone. Stroke. 2008; Vol. 39:543. x-wiley/crsRef/12667731
53. Kohen R, Cain KC, Buzaitis A, Johnson V, Becker KJ, Teri L, et al. Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms. Stroke 2011;42:2068-70. x-wiley/crsRef/12667732
54. Mitchell PH, Becker KJ, Buzaitis A, Cain KC, Johnson V, Kohen R, et al. Factors associated with treatment response to combined psychosocial and antidepressant treatment of post-stroke depression (PSD). Stroke 2010;41:e235-6. x-wiley/crsRef/12667733
55. Mitchell PH, Teri L, Veith R, Buzaitis A, Tirschwell D, Becker K, et al. Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depression. Journal of Stroke and Cerebrovascular Diseases 2008;17(3):109-15. x-wiley/crsRef/12667734
56. Mitchell PH, Veith R, Cain KC. Living well with stroke: psychosocial-behavioural intervention in post-stroke depression. Proceedings of the International Stroke Conference. USA, New Orleans, Louisiana: American Stroke Association, 2 February 2005:Abst. CTP39. x-wiley/crsRef/12667735
57. Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M, et al. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke 2009;40:3073-8. x-wiley/crsRef/12667736
58. NCT00194454. Psychosocial/behavioral intervention in post stroke depression (PSD). http://ClinicalTrials.gov/show/NCT00194454 (first received 19 September 2005). x-wiley/crsRef/12667737
59. Wong B. Nurse-led interventions decrease depression in stroke survivors. American Journal of Nursing 2009; Vol. 109, issue 11:19. x-wiley/crsRef/12667738
60. Murray V, Von Arbin M, Asberg M, Bartfai A, Berggren A, Landtblom A, et al. Double-blind placebo comparison of sertraline and placebo in stroke patients with depression. Unpublished 2003. x-wiley/crsRef/12667740
61. Murray V, Von Arbin M, Bartfai A, Berggren A, Landtblom A, Lundmark J, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. Journal of Clinical Psychiatry 2005;66(6):708-16. x-wiley/crsRef/12667741
62. Murray V, Von Arbin M, Varelius R, Olsson JE, Terent A, Samuelsson M, et al. Sertraline in poststroke depression: a controlled study. Stroke 2002;33(1):P292. x-wiley/crsRef/12667742
63. Kumar V. Post-stroke depression and treatment strategies including aniracetam. International Journal of Geriatric Psychopharmacology 1999;2:40-6. x-wiley/crsRef/12667744
64. Ohtomo E, Hirai S, Terashi A, Hasegawa K, Tazaki Y, Araki G, et al. Clinical evaluation of aniracetam on psychiatric symptoms related to cerebrovascular disease. Journal of Clinical Experimental Medicine 1991;156:143-87. x-wiley/crsRef/12667745
65. An 8-week, double-blind, placebo controlled, parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from depression following stroke. http://www.ctr.gsk.co.uk/Summary/Paroxetine/III_PAR_625.pdf issue par 625. x-wiley/crsRef/12667747
66. Ponzio F, Marini G, Riva E. The efficacy of paroxetine in some kinds of "critical" patients. European Neuropsychopharmacology 2001;11 Suppl 2:S49-S50 Abstract P.1.29. x-wiley/crsRef/12667748
67. Rampello L, Alvano A, Chiechio S, Raffaele R, Vecchio I, Malaguarnera M. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression: a random, placebo-controlled study. Archives of Gerontology and Geriatrics 2005;40:275-85. x-wiley/crsRef/12667750
68. Reding MJ, Orto LA, Winter SW, Fortuna IM, Di Ponte P, McDowell FH. Antidepressant therapy after stroke: a double-blind trial. Archives of Neurology 1986;43(8):763-5. x-wiley/crsRef/12667752
69. Robinson RG, Jorge RE, Clarence-Smith K. Double-blind randomized treatment of poststroke depression using nefiracetam. Journal of Neuropsychiatry and Clinical Neurosciences 2008;20(2):178-84. x-wiley/crsRef/12667755
70. Robinson RG, Jorge RE, Clarence-Smith K, Starkstein S. Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. Journal of Neuropsychiatry and Clinical Neurosciences 2009;21:144-51. x-wiley/crsRef/12667754
71. Robinson RG, Jorge RE, Clarence-Smith K. Double-blind randomized treatment of poststroke depression using nefiracetam. Journal of Neuropsychiatry and Clinical Neurosciences 2008;20(2):178-84. x-wiley/crsRef/12667758
72. Robinson RG, Jorge RE, Clarence-Smith K, Starkstein S. Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. Journal of Neuropsychiatry and Clinical Neurosciences 2009;21:144-51. x-wiley/crsRef/12667757
73. Sun H. The efficacy of repetitive transcranial magnetic stimulation in the treatment of post-stroke depression. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease 2013;11(3):321-2. x-wiley/crsRef/12667760
74. N0192165295. CALM: communication and low mood. National Research Register (first received 23 September 2009). x-wiley/crsRef/12667762
75. Thomas SA, Lincoln NB, Walker MF, Macniven J, Haworth H. Communication and low mood (CALM) study: a randomised controlled trial evaluating behaviour therapy for low mood in people with aphasia after stroke. International Journal of Stroke 2011;6 Suppl 2:27-8. x-wiley/crsRef/12667763
76. Thomas SA, Walker MF, Macniven JA, Haworth H, Lincoln NB. Communication and low mood (CALM): a randomized controlled trial of behavioural therapy for stroke patients with aphasia. Clinical Rehabilitation 2012;27(5):398-408. x-wiley/crsRef/12667764
77. Towle D, Lincoln NB, Mayfield LM. Evaluation of social work on depression after stroke. Clinical Rehabilitation 1989;3(2):89-96. x-wiley/crsRef/12667766
78. Towle D, Lincoln NB, Mayfield LM. Service provision and functional independence in depressed stroke patients and the effect of social work intervention on these. Journal of Neurology, Neurosurgery and Psychiatry 1989;52(4):519-22. x-wiley/crsRef/12667767
79. Towle D, Mayfield L, Lincoln M. Depression after stroke. Clinical Rehabilitation 1988;2:256. x-wiley/crsRef/12667768
80. Wang X, Song J, Mu J. The effect of psychotherapy on depression and cognitive function of patients with cerebral stroke. Chinese Mental Health Journal 2004;18:778-81. x-wiley/crsRef/12667770
81. Chen Y, Guo JJ, Zhan S, Paul NC. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Annals of Pharmacotherapy 2006;40:2115-22. x-wiley/crsRef/12667772
82. Wang ZM, Wang P, You LL. Study of effects of fluoxetine in patients with post-stroke depression, a random placebo-controlled study. Chinese Journal of Practical Nervous Diseases 2005; Vol. 8:80-1. x-wiley/crsRef/12667773
83. He Y, Wang X. A clinical study of paroxetine joint psychotherapy in treating poststroke depression with anxiety. Chinese Journal of Practical Nervous Diseases 2006;9(1):34-5. x-wiley/crsRef/12667775
84. Wang X, He Y, Xiao CL. A clinical trial of paroxetine and psychotherapy in patients with poststroke depression and anxiety. Chinese Mental Health Journal 2005;19:564-6. x-wiley/crsRef/12667776
85. Deans CF, Jack CIA. Evaluation of motivational interviewing early after acute stroke: a randomized controlled trial. Clinical Rehabilitation 2006;20:731-6. x-wiley/crsRef/12667778
86. Sutton C, Dickinson H, Leathley M, Hills K, Auton M, Lightbody E, et al. Motivational interviewing: altering outcome after stroke. 12th European Stroke Conference. Valencia, Spain, 2003 May 21-24:103. x-wiley/crsRef/12667779
87. Watkins CL, Auton MF, Deans CF, Dickinson HA, Jack CIA, Lightbody CE, et al. Motivational interviewing early after acute stroke: a randomized, controlled trial. Stroke 2007;38:1004-9. x-wiley/crsRef/12667780
88. Watkins CL, Wathan JV, Leathley MJ, Auton MF, Deans CF, Dickinson HA, et al. The 12-month effects of early motivational interviewing after acute stroke: a randomized controlled trial. Stroke 2011;42:1956-61. x-wiley/crsRef/12667781
89. Wiart L, Gassies TD, France B, Petit H, Debelleix D. A double-blind, placebo controlled trial to study the efficacy and tolerance of fluoxetine in the treatment of early post stroke depression. Proceedings of the 152nd Annual Meeting of the American Psychiatric Association. USA, Washington: American Psychiatric Association, 15-20 May 1999. x-wiley/crsRef/12667783
90. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000;31(8):1829-32. x-wiley/crsRef/12667784
91. Yang J, Zhao Y, Bai S. Controlled study on antidepressant treatment of patients with post-stroke depression. Chinese Journal of Psychology 2002;16(12):871-2. x-wiley/crsRef/12667786
92. Yang M. A comparative study of high frequency repetitive transcranial magnetic stimulation in the treatment of post stroke depression. Stroke Nervous Disorders 2013;20(5):303-5. x-wiley/crsRef/12667788
93. Yang L, Liu Y, Liu, L, Qi, X, Shi W, Lu C, et al. The curative effect of different frequency repetitive transcranial magnetic stimulation on patients with depression after stroke. Chinese Journal of Practical Nervous Diseases 2014;17(22):18-20. x-wiley/crsRef/12667790
94. Yang L, Liu Y, Liu, L, Qi, X, Shi W, Lu C, et al. The curative effect of different frequency repetitive transcranial magnetic stimulation on patients with depression after stroke. Chinese Journal of Practical Nervous Diseases 2014;17(22):18-20. x-wiley/crsRef/12667792
95. Zhang Z, Mu J, Geng G-H, Li Q, Song J-G. Effects of repetitive transcranial magnetic stimulation on depression and cognition in the treatment of post-stroke depression. Chinese Journal of Physical Medical Rehabilitation 2013;35(3):197-200. x-wiley/crsRef/12667794
96. Zhao H-W, Zhou C-X, Su X-L, Xiao X-C, Guo Y. Effect of mental intervention on post-stroke depression and rehabilitation of neurological function. Chinese Journal of Clinical Rehabilitation 2004;8(13):2408-9. x-wiley/crsRef/12667796
97. Zheng F. Clinical observation of ultra-low frequency transcranial magnetic stimulation in the treatment of post stroke depression. Today Nurse 2016;6:116-7. x-wiley/crsRef/12667798
98. Aben L, Heijenbrok-Kal MH, Ponds RWHM, Busschbach JJV, Ribbers GM. Long-lasting effects of a new memory self-efficacy training for stroke patients: a randomized controlled trial. Neurorehabilitation and Neural Repair 2014;28(3):199-206. x-wiley/crsRef/12667800
99. Aben L, Heijenbrok-Kal MH, van Loon EMP, Groet E, Ponds RWHM, Busschbach JJV, et al. Training memory self-efficacy in the chronic stage after stroke: a randomized controlled trial. Neurorehabilitation and Neural Repair 2013;27(2):110-7. x-wiley/crsRef/12667801
100. Agnoli A, Fioravanti M, Lechner H. Efficacy of CDP-Choline in chronic cerebral vascular diseases (CCVD). In: Appia V, Kennedy EP, Nilsson BI, Galletti P editor(s). Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. New York: Elsevier, 1985:305-15. x-wiley/crsRef/12667803
101. Bai B, Yan Z, Hao Y, Zhang Z, Li G, Dekker J, et al. A randomised controlled multimodal intervention trial in patients with ischaemic stroke in Shandong, China: design and rationale. Lancet 2017;390(1):13. x-wiley/crsRef/12667805
102. Bramanti P, Ricci RM, Di Bella P, De Luca GP, Sessa E, Di Leo M, et al. Neuropsychological and clinical evaluation after administration of TRH-T in cerebrovascular pathology [Valutazioni neuropsicologiche e cliniche dopo somminitrazione di TRH-T neila patologia cerebrovascolare]. Rassegna di Medicina Interna 1989;X(4):157-61. x-wiley/crsRef/12667807
103. Casella C, Sokolow J. A study to determine the energizing effects of iproniazid (marsilid) on a group of hemiplegics. Archives of Physical Medicine and Rehabilitation 1960;41:381-5. x-wiley/crsRef/12667809
104. Chang K, Zhang H, Xia Y, Chen C. Testing the effectiveness of knowledge and behavior therapy in patients of hemiplegic stroke. Topics in Stroke Rehabilitation 2011;18(5):525-35. x-wiley/crsRef/12667811
105. Cheng HY. The effect of a psychoeducational intervention on stroke family caregivers' outcomes and stroke survivors' utilisation of health and social services. Dissertation Abstracts International: Section B: The Sciences and Engineering 2016; Vol. 76. x-wiley/crsRef/12667813
106. Choi-Kwon S, Choi J, Kwon SU, Kang D, Kim JS. Fluoxetine is not effective in the treatment of poststroke fatigue: a double-blind, placebo controlled study. Cerebrovascular Diseases 2007;23:103-8. x-wiley/crsRef/12667815
107. Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS. Fluoxetine improves the quality of life in patients with post-stroke emotional disturbances. Cerebrovascular Diseases 2008;26:266-71. x-wiley/crsRef/12667816
108. Choi-Kwon S, Han SW, Kwon SU, Kang D, Kim CS, Kim JS. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006;37:156-61. x-wiley/crsRef/12667817
109. Choi-Kwon S, Kwon SU, Kang DW, Kim JS. Fluoxetine improves the quality of life in patients with post-stroke emotional disturbances. Stroke 2009;40:e282. x-wiley/crsRef/12667818
110. Kim JS. Post-stroke emotional disturbances. Journal of Stroke 2005;18(3):244. x-wiley/crsRef/12667819
111. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurology 2011;10:123-30. x-wiley/crsRef/12667821
112. Clark MS, Rubenach S, Winsor A. A randomized controlled trial of an education and counselling intervention for families after stroke. Clinical Rehabilitation 2003;17(7):703-12. x-wiley/crsRef/12667823
113. Delbari A, Salman-Roghani R, Lokk J. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial. European Neurology 2011;66:7-13. x-wiley/crsRef/12667825
114. Downes B, Rooney V, Oyebode JR, Roper-Hall A, Mayer P, Main A. The effect of giving information and counselling on depression and anxiety in stroke survivors and carers (The Birmingham Stroke Counselling Project). Unpublished 1995. x-wiley/crsRef/12667827
115. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Treatment of depression in the elderly: effect of physical illness on response. International Journal of Geriatric Psychiatry 1997;12:1189-94. x-wiley/crsRef/12667829
116. Finkenzeller W, Zobel I, Rietz S, Schramm E, Berger M. Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness. Der Nervenarzt 2009;80:805-12. x-wiley/crsRef/12667831
117. Hadidi N, Buckwalter K, Lindquist R, Rangen C. Feasibility of a pilot study of problem-solving therapy for stroke survivors. Rehabilitation Nursing 2014;5:327-337. x-wiley/crsRef/12667833
118. Hu Z, Hu Y, Lu Q. Impact of early rehabilitation therapy on post stroke depression. Chinese Journal of Clinical Rehabilitation 2003;3(15):1. x-wiley/crsRef/12667835
119. ISRCTN88489864. Influence of a single dose of fluoxetine on muscle activation patterns and functional ability in chronic stroke patients. http://www.isrctn.com/ISRCTN88489864 (first received 23 July 2005). x-wiley/crsRef/12667837
120. Jiang JB, Li GC. Effects of post-stroke depression and anti-depression therapy on rehabilitation of neurological function in patients with meta method. Chinese Journal of Clinical Rehabilitation 2004;8(31):6829-31. x-wiley/crsRef/12667839
121. Jorge RE, Robinson RG, Tateno A, Narushima K, Acion L, Moser D, et al. Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biological Psychiatry 2004;55:398-405. x-wiley/crsRef/12667841
122. Jorge RE, Moser DJ, Acion M, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Archives of General Psychiatry 2008;65(3):268-76. x-wiley/crsRef/12667843
123. Kim BR, Kim D, Chun MH, Yi JH, Kwon JS. Effect of repetitive transcranial magnetic stimulation on cognition and mood in stroke patients: a double-blind, sham-controlled trial. American Journal of Physical Medicine and Rehabilitation 2010;89(5):362-8. x-wiley/crsRef/12667845
124. Kim BR, Kim D, Chun MH, Yi JH, Kwon JS. Effect of repetitive transcranial magnetic stimulation on cognition and mood in stroke patients: a double-blind, sham-controlled trial. American Journal of Physical Medicine and Rehabilitation 2010;89(5):362-8. x-wiley/crsRef/12667847
125. Kim JS, Lee E-J, Chang D, Park J-H, Ahn SH, Cha J-K, et al. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind,randomised, placebo-controlled study. Lancet Psychiatry 2017;4(1):33-43. x-wiley/crsRef/12667849
126. Kim K-U, Kim S-H, An T-G. The effects of repetitive transcranial magnetic stimulation (rTMS) on depression, visual perception, and activities of daily living in stroke patients. Journal of Physical Therapy Science 2017;29:1036–9. x-wiley/crsRef/12667851
127. Kootker JA, Fasotti L, Rasquin SMC, van Heugten CM, Geurts ACH. The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): the Restore4Stroke-PSDA trial. BMC Neurology 2012;12(51):1-8. x-wiley/crsRef/12667853
128. Kootker JA, Rasquin SMC, Lem FC, van Heughten CM, Fasotti L, Geurts ACH. Augmented cognitive behavioral therapy for poststroke depressive symptoms: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2017;98:687-94. x-wiley/crsRef/12667854
129. Kootker JA, Rasquin SMC, Smits P, Geurts AC, van Heugten CM, Fasotti L. An augmented cognitive behavioural therapy for treating post-stroke depression: description of a treatment protocol. Clinical Rehabilitation 2015;29(9):833-43. x-wiley/crsRef/12667855
130. Laska AC, van Arbin M, Kahan T, Hellblom A, Murray V. Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovascular Diseases 2005;19(2):125-32. x-wiley/crsRef/12667857
131. Leijon G, Boivie J. Central post-stroke pain: a controlled trial of amitriptyline and carbamazepine. Pain 1989;36(1):27-36. x-wiley/crsRef/12667859
132. Lobjanidze N, Dzagnidze A, Jeiranashvili A, Kukava M, Beridze M, Khachiashvili M, et al. Long-term effects of the use of citicoline (ceraxone) in the post-stroke cognitive-mood impairment. Cerebrovascular Diseases 2010; Vol. 5, issue 1:14. x-wiley/crsRef/12667861
133. Marui L, Arboix A, Marti-Vilalta JL. Efficacy of antidepressive treatment in affective disorders associated to ischemic vascular disease. Neurologia 1988;3 Suppl 3:10. x-wiley/crsRef/12667863
134. Meara JR. A randomised double blind placebo controlled study of the treatment of post stroke depression. National Research Register. x-wiley/crsRef/12667865
135. Meara RJ, Thalanany M, Balonwu V, Hobson P. The treatment of depression after stroke with the selective serotonin reuptake inhibitor sertraline. Cerebrovascular Diseases 1998;8 Suppl 4:90. x-wiley/crsRef/12667866
136. Narushima K, Paradiso S, Moser D, Jorge R, Robinson R. Effect of antidepressant therapy on executive function after stroke. British Journal of Psychiatry 2007;190:260-5. x-wiley/crsRef/12667868
137. Ohtomo E, Kutsuzawa T, Araki G, Hirai S, Terashi A, Kuzuya F, et al. Clinical usefulness of tiapride on psychiatric symptoms caused by cerebrovascular disorders. Clinical Evaluation 1985;13:295-332. x-wiley/crsRef/12667870
138. NCT00178529. Intervention for stroke survivors and their spousal caregivers. https://clinicaltrials.gov/ct2/show/NCT00178529 (first received 19 July 2001). x-wiley/crsRef/12667872
139. Ostwald S, Godwin K, Cron S, Kelley C, Hersch G, Davis S. Home-based psychoeducational and mailed information programs for stroke-caregiving dyads post-discharge: a randomized trial. Disability and Rehabilitation 2014;36(1):55-62. x-wiley/crsRef/12667873
140. Ostwald SK, Davis S, Hersch G, Kelley C, Godwin KM. Evidence based educational guidelines for stroke survivors after discharge home. Journal of Neuroscience Nursing 2008;40(3):173-91. x-wiley/crsRef/12667874
141. Ostwald SK, Wasserman J, Davis S. Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabilitation Nursing 2006;31(1):10-4. x-wiley/crsRef/12667875
142. Otomo E, Tohgi H, Hirai S, Gotoh F, Hasegawa K, Tazaki Y, et al. Clinical evaluation of YM-08054 (indeloxazine) in the treatment of cerebrovascular disorder. Igaku no Ayumi 1986;136(7):535-55. x-wiley/crsRef/12667877
143. Raffaele R, Rampello L, Vecchio I, Tornali C, Malaguanera M. Trazodone therapy of the post-stroke depression. Archives of Gerontology and Geriatrics 1996;22 Suppl 1:217-20. x-wiley/crsRef/12667879
144. Rich TL, Menk J, Krach LE, Feyma T, Gillick BT. Repetitive transcranial magnetic stimulation/behavioural intervention clinical trial: long-term follow-up of outcomes in congenital hemiparesis. Journal of Child and Adolescent Psychopharmacology 2016;26(7):598-605. x-wiley/crsRef/12667881
145. Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier T, Newman M, et al. Nortriptyline versus fluoxetine in the treatment of depression and in-short-term recovery after stroke: a placebo-controlled, double-blind study. American Journal of Psychiatry 2000;157(3):351-9. x-wiley/crsRef/12667883
146. Robinson RG, Jorge RE, Long J. Prevention of poststroke mortality using problem-solving therapy or escitalopram. American Journal of Geriatric Psychiatry 2017;25(5):512-9. x-wiley/crsRef/12667885
147. Rudberg AS, Isaksson E, Lundstrom E. Efficacy of fluoxetine: a randomised controlled trial in stroke, the effects study in Sweden. European Stroke Journal 2017;2(1 Suppl 1):320-1. x-wiley/crsRef/12667887
148. Sieger FS, Poveda MYP, Moreno AP, Sanchez JAM, Romero LAL, Guzman LCR, et al. Effects of repetitive transcranial magnetic stimulation in aphasic stroke: a randomised double-blind controlled clinical trial. Neurology 2018;90(15 Suppl 1):P5.004. x-wiley/crsRef/12667889
149. Sivenius J, Sarasoja T, Aaltonen H, Heinonen E, Kilkku O, Reinikainen K. Selegiline treatment facilitates recovery after stroke. Journal of Neurologic Rehabilitation 2001;15(3):183-90. x-wiley/crsRef/12667891
150. Su XL, Xiao XC. Effect of psychotherapy on the motor functional rehabilitation in patients with post-stroke depression. Chinese Journal of Clinical Rehabilitation 2004;8(19):3720-1. x-wiley/crsRef/12667893
151. Sun B, Chan JL. Effects of psychological rehabilitation on the recovery of hemiplegia patients after stroke. Modern Rehabilitation 2000;4(1):36-7. x-wiley/crsRef/12667895
152. Szepfalusi N, Nemeth VL, Vekony T, Imre N, Balogh R, Holczer A, et al. Ten-day cognitive training program combined with transcranial direct current stimulation (tDCS) in stroke rehabilitation - a sham controlled study. European Neuropsychopharmacology 2017;27 Suppl 4:S1038-9. x-wiley/crsRef/12667897
153. Szepfalusi N, Nemeth VL, Vekony T, Imre N, Balogh R, Holczer A, et al. The use of transcranial direct current stimulation (tDCS) combined with cognitive training in stroke rehabilitation - a sham-controlled pilot study. Cerebrovascular Diseases 2017;43 Suppl 1:61. x-wiley/crsRef/12667898
154. NCT01525524. Treatment of major depressive disorder post stroke with transcranial direct current stimulation. https://clinicaltrials.gov/ct2/show/NCT01525524 (first received 3 February 2012). x-wiley/crsRef/12667900
155. Valiengo LCL, Goulart AC, de Oliveira JF, Benseñor IM, Lotufo PA, Brunoni AR. Transcranial direct current stimulation for the treatment of post-stroke depression: results from a randomised, sham-controlled, double-blinded trial. Journal of Neurology, Neurosurgery and Psychiatry 2017;88:170-5. x-wiley/crsRef/12667901
156. Visser MM, Heijenbrok-Kal MH, van't Spijker A, Busschbach JJV, Ribbers GM. Poster 44: problem solving therapy during outpatient rehabilitation for stroke: short-term results of a randomized controlled trial. Stroke 2014; Vol. Suppl 1:28. x-wiley/crsRef/12667903
157. Visser MM, Heijenbrok-Kal MH, van't Spijker A, Busschbach JJV, Ribbers GM. Problem solving therapy during outpatient stroke rehabilitation improves coping and HRQoL: a randomized controlled trial. Stroke 2015;1:1-28. x-wiley/crsRef/12667904
158. Visser MM, Heijenbrok-Kal MH, van't Spijker A, Ribbers GM, Busschbach JJV. The effectiveness of problem solving therapy for stroke patients: study protocol for a pragmatic randomised controlled trial. BMC Neurology 2013;13(67):1-7. x-wiley/crsRef/12667905
159. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke: further evidence. Stroke 1995;26(12):2254-9. x-wiley/crsRef/12667907
160. Wang P. Influence of magnetic stimulation to treat post stroke depression on recovery of neurological function. Chinese Nursing Research 2009;23(5):1356-7. x-wiley/crsRef/12667909
161. Chen W, Wang GF, Chen XH, Sheng YL, Zhu H. Effects of paroxetine on function recovery in patients with poststroke depression. Chinese Journal of Clinical Rehabilitation 2002;6(13):2014-5. x-wiley/crsRef/12667911
162. Chen W, Wang GF, Chen XH, Sheng YL, Zhu H. Effects of paroxetine on function recovery in patients with poststroke depression. Chinese Journal of Clinical Rehabilitation 2002;6(13):2014-5. x-wiley/crsRef/12667913
163. Ding D, Zhang Z. Combination of paroxetine and psychotherapy in the treatment of post-stroke depression. Shanghai Archives of Psychiatry 2005;17(2):89-91. x-wiley/crsRef/12667915
164. Evans RL, Kleinman L, Halar EM, Herzer K. Predicting outcome of group counselling with severely disabled patients. American Journal of Physical Medicine 1985;64(1):24-31. x-wiley/crsRef/12667917
165. Finkenzeller W, Zobel I, Rietz S, Schramm E, Berger M. Interpersonal psychotherapy and pharmacotherapy in post-stroke depression [Interpersonelle Psychotherapie und Pharmakotherapie bei Post-Stroke-Depression]. Nervenarzt 2009;80:805-12. x-wiley/crsRef/12667919
166. Hanspal R. The effectiveness of sertraline in clinical management of depression with or without lability in brain-injured. National Research Register. [N0388126828]x-wiley/crsRef/12667921
167. He C. The effect of psychological intervention combined with amitriptyline on patients with depression after stroke. Chinese Journal of Clinical Rehabilitation 2003;7(5):850. x-wiley/crsRef/12667923
168. He Y. A clinical study of paroxetine joint psychotherapy in treating poststroke depression with anxiety. Chinese Journal of Practical Nervous Diseases 2006;9(1):34-5. x-wiley/crsRef/12667925
169. He Y. Prospective study of effects of paroxetine with mental intervention on depression and anxiety after stroke. Nervous Disease and Mental Health 2005;5(1):6-8. x-wiley/crsRef/12667926
170. Huang C, Shi G, Bai C. A comparative study of venlafaxine plus cognitive therapy in the treatment of post-stroke depression. Chinese Journal of Behavioral Medical Science 2005;14(9):790-1. x-wiley/crsRef/12667928
171. Katz RA, Hubbard DJ, Blaine J. The effect of group psychotherapy on post-stroke depression. Rehabilitation Psychology 1998;43(2):178. x-wiley/crsRef/12667930
172. Latow J. Psychotherapy and its effect on depression, sick-role identification and rehabilitation outcome for stroke victims. Archives of Physical Medicine and Rehabilitation 1983;64(10):511-2. x-wiley/crsRef/12667932
173. Lee NG, Choi IS, Kim JH, Lee SY, Han JY. The effect of repetitive transcranial magnetic stimulation on the post-stroke depression. Proceedings of the Proceedings of 3rd World Congress of the International Society of Physical and Rehabilitation Medicine - ISPRM. Brazil, Sao Paulo, 10-14 April 2005:105-9. x-wiley/crsRef/12667934
174. Liu J, Li X. High- frequency transcranial magnetic stimulation for alleviating post-stroke depression. Chinese Journal of Physical Medical Rehabilitation 2010;32(7):513-5. x-wiley/crsRef/12667936
175. Pearson V. Educational intervention reduces occurrence of depression in community-dwelling stroke survivors. Stroke 2005;36(2):423. x-wiley/crsRef/12667938
176. Razazian N, Esmaeili O, Almasi A. Effect of fluoxetine on motor improvement in ischemic stroke patients: a double blind clinical trial study. Zahedan Journal of Research in Medical Sciences 2016;18(7):e7549. x-wiley/crsRef/12667940
177. Tang LY, Ye JH. Cognitive therapy on depression and cognitive dysfunction after stroke. Nursing Journal of Chinese People's Liberation Army 2002;19(4):6-7. x-wiley/crsRef/12667942
178. Wang J, Zhang M, Xu L. The clinical observation of post-stroke depression improvement by repetitive transcranial magnetic stimulation. Chinese Journal of Rehabilitation 2015;6(30):167-70. x-wiley/crsRef/12667944
179. Yan TT, He LM, Gu ZT. A randomized, controlled study of high- and low-frequency rTMS on the treatment outcome for post stroke depression [??????????????????????????]. Qingdao Yiyao Weisheng 2010;42(2):81-5. x-wiley/crsRef/12667946
180. Yan TT, He LM, Gu ZT. A randomized, controlled study of high- and low-frequency rTMS on the treatment outcome for post stroke depression [??????????????????????????]. Qingdao Yiyao Weisheng 2010;42(2):81-5. x-wiley/crsRef/12667948
181. Yan TT, He LM, Gu ZT. A randomized, controlled study of high- and low-frequency rTMS on the treatment outcome for post stroke depression [[??????????????????????????]]. Qingdao Yiyao Weisheng 2010;42(2):81-5. x-wiley/crsRef/12667950
182. Yan TT, He LM, Gu ZT. A randomized, controlled study of high- and low-frequency rTMS on the treatment outcome for post stroke depression [??????????????????????????]. Qingdao Yiyao Weisheng 2010;42(2):81-5. x-wiley/crsRef/12667952
183. Kirkevold M, Bragstad LK, Bronken BA, Kvigne K, Martinsen R, Hjelle EG, et al. Promoting psychosocial well-being following stroke: study protocol for a randomized, controlled trial. BMC Psychology 2018;6(12):1-12. x-wiley/crsRef/12667954
184. NCT03056287. Exercise and brain stimulation for post-stroke. https://clinicaltrials.gov/ct2/show/NCT03056287 (first received 17 February 2017). x-wiley/crsRef/12667956
185. Tang Y, Chen A, Zhu S, Yang L, Zhou J, Pan S, et al. Repetitive transcranial magnetic stimulation for depression after basal ganglia ischaemic stroke: protocol for a multicentre randomised double-blind placebo-controlled trial. BMJ Open 2017;8:1-7. x-wiley/crsRef/12667958
186. Thomas SA, Coates E, das Nair R, Lincoln NB, Cooper C, Palmer R, et al. BEhavioural Activation therapy for Depression after Stroke (BEADS): a study protocol for a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression. Pilot and Feasibility Studies 2016;2(45):1-12. x-wiley/crsRef/12667960
187. Xu SM, Zou DZ, Shen LY, Zhou XY, Pu JC, Dong MX, et al. Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression. Medicine 2016;95(45):e5349. x-wiley/crsRef/12667962
188. Anderson CS, Linto J, Stewart-Wynne EG. A population-based assessment of the impact and burden of caregiving for long-term stroke survivors. Stroke 1995;26:843-9.
189. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. Third Edition. Washington, DC: American Psychiatric Association, 1987.
190. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Fourth. Washington, DC: American Psychiatric Association, 1994.
191. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-V. Fifth. Arlington, VA: American Psychiatric Publishing, 2013.
192. Astrom M. Generalized anxiety disorder in stroke patients: a 3-year longitudinal study. Stroke 1996;27:270-5.
193. Atkins D, Best D, Briss PA, Eccles M, Falck-Yitter Y, Flottorp G, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
194. Ayerbe L, Ayis S, Wolfe CDA, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. British Journal of Psychiatry 2013;202:14-21.
195. Beck AT, Ward C, Mendelson M. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561-71.
196. Bucur M, Papagno C. A systematic review of noninvasive brain stimulation for post-stroke depression. Journal of Affective Disorders 2018;238:69-78.
197. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM. Prevalence of depression after stroke: the Perth Community Stroke Study. British Journal of Psychiatry 1995;166:320-7.
198. Burvill PW, Johnson GA, Chakera TMH, Stewart-Wynne EG, Anderson CS, Jamrozik KD. The place of site of lesion in the aetiology of post-stroke depression. Cerebrovascular Diseases 1996;6:208-15.
199. Burvill P, Johnson G, Jamrozik KD, Anderson C. Risk factors for post-stroke depression. International Journal of Geriatric Psychiatry 1997;12:219-26.
200. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: a systematic review. Lancet 2000;356:122-6.
201. Chan A, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. Journal of the American Medical Association 2004;291:2457-65.
202. Chen Y, Guo JJ, Zhan S, Patel NC. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Annals of Pharmacotherapy 2006;40(12):2115–22.
203. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391:1357-66.
204. Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
205. Deutsch A, Braun S, Granger CV. The Functional Independence Measure (FIM Instrument). Journal of Rehabilitation Outcomes Measures 1997;1:67-71.
206. Ebrahim S, Barer D, Nouri F. Affective illness after stroke. British Journal of Psychiatry 1987;151:52-6.
207. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189-98.
208. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effect and depression severity: a patient-level meta-analysis. JAMA 2010;303(1):47-53.
209. Gill D, Hatcher S. Antidepressants for depression in medical illness. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001312.pub2]
210. Goldberg DP. The detection of psychiatric illness by questionnaire. Maudsley Monograph No 21. Oxford: Oxford University Press, 1972.
211. Gompertz P, Pound P, Ebrahim S. The reliability of stroke outcome measurement. Clinical Rehabilitation 1993;7:290-6.
212. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org. GRADEproGDT. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org, 2015.
213. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD003689]
214. Hackett M, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. World Stroke Organisation 2014;9(December):1017-25.
215. Hamilton M. Rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
216. Herrmann N, Backe SE, Lawrence J, Szekely C, Szalai JP. The Sunnybrook stroke study: a prospective study of depressive symptoms and functional outcome. Stroke 1998;29:618-24.
217. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.
218. House A. Mood disorders after stroke: a review of the evidence. International Journal of Geriatric Psychiatry 1987;2:211-21.
219. House A, Dennis M, Hawton K, Warlow C. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire community stroke project. Age and Aging 1989;18:371-9.
220. House A, Dennis M, Mogridge L, Warlow C, Hawton K, Jones L. Mood disorders in the year after first stroke. British Journal of Psychiatry 1991;158:83-92.
221. House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001;32:696-701.
222. Johnson GA. Research into psychiatric disorder after stroke: the need for further studies. Australian & New Zealand Journal of Psychiatry 1991;25:358-70.
223. Katona CLE, Watkin V. Depression in old age. Reviews in Clinical Gerontology 1995;5:427-41.
224. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. Journal of the American Medical Association 2003;289(23):3152-60.
225. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine 2008;5(2):0260-8.
226. Lima MS, Moncrieff J. Drugs versus placebo for dysthymia. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001130]
227. Lyden PD, Lu M, Levine SR, Brott TG, Broderick J, the NINDS rtPA Stroke Study Group. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke 2001;32:1310-7.
228. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965;14:61-5.
229. McCusker J, Cole M, Keller E, Bellavance F, Berard A. Effectiveness of treatments of depression in older ambulatory patients. Archives of Internal Medicine 1998;158:705-12.
230. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD009286]
231. Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctot KL, Liu BA, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. Journal of Affective Disorders 1997;46:191-217.
232. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
233. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. American Journal of Psychiatry 1993;150:124-9.
234. Normand ST. Meta-analysis: formulating, evaluating, combining, and reporting. Statistics in Medicine 1999;18:321-59.
235. Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Archives of Neurology 1990;47:785-9.
236. Paul SL, Dewey HM, Sturm JW, Macdonell RAL, Thrift AG. Prevalence of depression and use of antidepressant medication at 5-years poststroke in the North East Melbourne Stroke Incidence Study. Stroke 2006;37:2854-5.
237. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
238. Robinson RG, Bolla-Wilson K, Kaplan E, Lipsey JR, Price TR. Depression influences intellectual impairment in stroke patients. British Journal of Psychiatry 1986;148:541-7.
239. Schunemann HJ, Oxman AD, Higgins JP, Vist GE, Glazziou P, Guyatt GH. Chapter 11. Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org, 2011.
240. Sharpe M, Hawton K, House A, Molyneux A, Sandercock P, Bamford J, et al. Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume. Psychological Medicine 1990;20:815-28.
241. Shena XY, Liua MY, Chenga Y, Jiab C, Pana XY, Goua QY, et al. Repetitive transcranial magnetic stimulation for the treatment of poststroke depression: a systematic review and meta-analysis of randomized controlled clinical trials. Journal of Affective Disorders 2017;211:65-74.
242. Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H. Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke 1986;17:1102-7.
243. Snow V, Lascher S, Mottur-Pilson C, for the American College of Physicians-American Society of Internal Medicine. Pharmacologic treatment of acute major depression and dysthymia. Annals of Internal Medicine 2000;132(9):738-42.
244. Stenager EN, Madsen C, Stenager E, Boldsen J. Suicide in patients with stroke: epidemiological study. BMJ 1998;316:1206.
245. Turner A, Hambridge J, White J, Carter G, Clover K, Nelson L, Hackett M. Depression screening in stroke: a comparison of alternative measures with the SCID (Major Depressive Episode) as criterion standard. Stroke 2012;43:1000-5.
246. Turner-Stokes L. Poststroke depression: getting the full picture. Lancet 2003;361(9371):1757-8.
247. Verhagen AP, de Vet HCW, de Bie RA, Boers M, van den Brandt PA. The art of quality assessment of RCTs included in systematic reviews. Journal of Clinical Epidemiology 2001;54:651-4.
248. Wilkinson P. Cognitive therapy with elderly people. Age and Ageing 1997;26:53-8.
249. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 1983;67:361-70.
250. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. American Journal of Psychiatry 2002;159(3):469-73.
251. Hackett ML, Anderson CS, House AO. Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD003437.pub2]
252. Hackett ML, Anderson CS, House AO. Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 2005;36:1092-7.
253. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD003437.pub3]